Prosecution Insights
Last updated: October 27, 2026

Mamon A Obeid, USPTO Patent Examiner

Listed by the USPTO as OBEID, MAMON A

Tech Center 3600 • Art Units: 3621 3683 3685 3686 3687 3699

This examiner grants 46% of resolved cases

Analysis

Mamon A. Obeid is an examiner in Tech Center 3600 and Art Unit 3621. He has 412 resolved cases with an allowance rate of 46.1 percent. The interview lift is 33.1 percent, which indicates an increase in the allowance rate for cases with an interview compared to the 46.1 percent baseline. This suggests that interviews are a productive strategy for advancing applications toward issuance.

The median time to allowance is 1974 days. His top corporate applicants include Siemens Healthineers AG, Fujifilm Corporation, and RESMED Pty Ltd. These companies are often represented by firms such as HARNESS, DICKEY & PIERCE, P.L.C., Harrity & Harrity, LLP \ Qualcomm, and Holland & Hart LLP. The 33.1 percent lift and the 1974 days median pendency provide a statistical basis for managing expectations. Practitioners can use these metrics to develop a data-driven strategy for applications assigned to this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

46.1%
Allow Rate
-5.9% vs TC avg
442
Total Applications
+33.1%
Interview Lift
1974
Avg Prosecution Days
Based on 412 resolved cases, 2023–2026

Rejection Statute Breakdown

24.7%
§101 Eligibility
5.0%
§102 Novelty
38.7%
§103 Obviousness
27.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18416782 MEDICAL INFORMATION PROCESSING APPARATUS, METHOD FOR OPERATING MEDICAL INFORMATION PROCESSING APPARATUS, AND MEDICAL INFORMATION PROCESSING PROGRAM Final Rejection FUJIFILM Corporation
18001631 SYSTEMS AND METHODS FOR IDENTIFYING INDIVIDUALS WITH A SLEEPING DISORDER AND A DISPOSITION FOR TREATMENT Final Rejection ResMed Pty Ltd
18576394 SYSTEM AND METHOD FOR GENERATING ADAPTIVE SUGGESTIONS FOR PATIENT CARE PLANS Non-Final OA KONINKLIJKE PHILIPS N.V.
18394086 GENERATING RECOMMENDATION INFORMATION BASED AT LEAST IN PART ON USER INTENT Non-Final OA QUALCOMM Incorporated
19474385 DATA ACQUISITION DEVICE Non-Final OA NTT DOCOMO, INC.
19311383 DEVICE AND METHOD FOR ORGAN POSITIONING ASSESSMENT Non-Final OA Siemens Healthineers AG
17953532 AUTOMATED DATA-BASED PROVISION OF A PATIENT-SPECIFIC MEDICAL ACTION RECOMMENDATION Final Rejection Siemens Healthcare GmbH
17817472 MACHINE LEARNING TECHNIQUES FOR GENERATING COHORTS AND PREDICTIVE MODELING BASED THEREOF Non-Final OA Optum, Inc.
18618327 MACHINE LEARNING-BASED SUMMARIZATION AND EVALUATION OF CLINICAL DATA Non-Final OA MatrixCare, Inc.
18608028 AUGMENTED REALITY IN HEALTHCARE COMMUNICATIONS Final Rejection Welch Allyn, Inc.
17260094 BRAIN INJURY MONITORING WITH RECOVERY TRAJECTORY Non-Final OA DUKE UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Mamon A Obeid's allowance rate?

46.1% of resolved applications examined by Mamon A Obeid were allowed (412 resolved cases), compared with 25.4% across Art Unit 3621 over the last five years.

Does an interview help with examiner Mamon A Obeid?

This examiner's interview lift is +33.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Mamon A Obeid take to allow a patent?

Applications allowed by Mamon A Obeid took 1,974 days on average from filing to allowance.

Which art unit does examiner Mamon A Obeid work in?

Mamon A Obeid examines applications in Art Unit 3621 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month